Literature DB >> 19722897

DNA vaccines in veterinary use.

Laurel Redding1, David B Weiner.   

Abstract

DNA vaccines represent a new frontier in vaccine technology. One important application of this technology is in the veterinary arena. DNA vaccines have already gained a foothold in certain fields of veterinary medicine. However, several important questions must be addressed when developing DNA vaccines for animals, including whether or not the vaccine is efficacious and cost effective compared with currently available options. Another important question to consider is how to apply this developing technology in a wide range of different situations, from the domestic pet to individual fish in fisheries with several thousand animals, to wildlife programs for disease control. In some cases, DNA vaccines represent an interesting option for vaccination, while in others, currently available options are sufficient. This review will examine a number of diseases of veterinary importance and the progress being made in DNA vaccine technology relevant to these diseases, and we compare these with the conventional treatment options available.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19722897      PMCID: PMC4425421          DOI: 10.1586/erv.09.77

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  116 in total

1.  Efficacy of foot-and-mouth disease vaccine in pigs with single dose immunization.

Authors:  P C Liao; Y L Lin; M H Jong; W B Chung
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

Review 2.  Overview of avian influenza DIVA test strategies.

Authors:  David L Suarez
Journal:  Biologicals       Date:  2005-10-28       Impact factor: 1.856

3.  Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays.

Authors:  Regina Hofmann-Lehmann; Ravi Tandon; Felicitas S Boretti; Marina L Meli; Barbara Willi; Valentino Cattori; Maria A Gomes-Keller; Pete Ossent; Matthew C Golder; J Norman Flynn; Hans Lutz
Journal:  Vaccine       Date:  2005-09-19       Impact factor: 3.641

Review 4.  Current status of veterinary vaccines.

Authors:  Els N T Meeusen; John Walker; Andrew Peters; Paul-Pierre Pastoret; Gregers Jungersen
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 5.  The potential of DNA vaccination against tumor-associated antigens for antitumor therapy.

Authors:  Katharina Haupt; Michael Roggendorf; Klauss Mann
Journal:  Exp Biol Med (Maywood)       Date:  2002-04

6.  Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity.

Authors:  Julie K Levy; H Morgan Scott; Jessica L Lachtara; P Cynda Crawford
Journal:  J Am Vet Med Assoc       Date:  2006-02-01       Impact factor: 1.936

7.  Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine.

Authors:  D A Harbour; D A Gunn-Moore; T J Gruffydd-Jones; S M A Caney; J Bradshaw; O Jarrett; A Wiseman
Journal:  Vaccine       Date:  2002-07-26       Impact factor: 3.641

8.  Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate.

Authors:  Jean Paul Cano; Scott A Dee; Michael P Murtaugh; Carlos Pijoan
Journal:  Vaccine       Date:  2007-04-03       Impact factor: 3.641

9.  DNA vaccination against pseudorabies virus and bovine respiratory syncytial virus infections of young animals in the face of maternally derived immunity.

Authors:  C Hamers; V Juillard; L Fischer
Journal:  J Comp Pathol       Date:  2007-06-05       Impact factor: 1.311

10.  Vaccination with recombinant Mycobacterium avium subsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challenge.

Authors:  Kumanan Kathaperumal; Sung-Un Park; Sean McDonough; Susan Stehman; Bruce Akey; John Huntley; Susan Wong; Chao-Fu Chang; Yung-Fu Chang
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

View more
  23 in total

Review 1.  DNA vaccines for targeting bacterial infections.

Authors:  Mariana Ingolotti; Omkar Kawalekar; Devon J Shedlock; Karuppiah Muthumani; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

2.  Dose imprecision and resistance: free-choice medicated feeds in industrial food animal production in the United States.

Authors:  David C Love; Meghan F Davis; Anna Bassett; Andrew Gunther; Keeve E Nachman
Journal:  Environ Health Perspect       Date:  2010-10-28       Impact factor: 9.031

Review 3.  Strategies and hurdles using DNA vaccines to fish.

Authors:  Linn B Hølvold; Anne I Myhr; Roy A Dalmo
Journal:  Vet Res       Date:  2014-02-19       Impact factor: 3.683

4.  Magnetic Nanovectors for the Development of DNA Blood-Stage Malaria Vaccines.

Authors:  Fatin M Nawwab Al-Deen; Sue D Xiang; Charles Ma; Kirsty Wilson; Ross L Coppel; Cordelia Selomulya; Magdalena Plebanski
Journal:  Nanomaterials (Basel)       Date:  2017-02-10       Impact factor: 5.076

5.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10

6.  DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.

Authors:  Ilin Chuang; Martha Sedegah; Susan Cicatelli; Michele Spring; Mark Polhemus; Cindy Tamminga; Noelle Patterson; Melanie Guerrero; Jason W Bennett; Shannon McGrath; Harini Ganeshan; Maria Belmonte; Fouzia Farooq; Esteban Abot; Jo Glenna Banania; Jun Huang; Rhonda Newcomer; Lisa Rein; Dianne Litilit; Nancy O Richie; Chloe Wood; Jittawadee Murphy; Robert Sauerwein; Cornelus C Hermsen; Andrea J McCoy; Edwin Kamau; James Cummings; Jack Komisar; Awalludin Sutamihardja; Meng Shi; Judith E Epstein; Santina Maiolatesi; Donna Tosh; Keith Limbach; Evelina Angov; Elke Bergmann-Leitner; Joseph T Bruder; Denise L Doolan; C Richter King; Daniel Carucci; Sheetij Dutta; Lorraine Soisson; Carter Diggs; Michael R Hollingdale; Christian F Ockenhouse; Thomas L Richie
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

Review 7.  Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination.

Authors:  Kouji Kobiyama; Nao Jounai; Taiki Aoshi; Miyuki Tozuka; Fumihiko Takeshita; Cevayir Coban; Ken J Ishii
Journal:  Vaccines (Basel)       Date:  2013-07-18

Review 8.  M2e-Based Universal Influenza A Vaccines.

Authors:  Lei Deng; Ki Joon Cho; Walter Fiers; Xavier Saelens
Journal:  Vaccines (Basel)       Date:  2015-02-13

Review 9.  Allergens are not pathogens: why immunization against allergy differs from vaccination against infectious diseases.

Authors:  Richard Weiss; Sandra Scheiblhofer; Josef Thalhamer
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

10.  Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.

Authors:  Yingying Xu; Pak-Wai Yuen; Jenny Ka-Wing Lam
Journal:  Pharmaceutics       Date:  2014-07-10       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.